Intravitreous ranibizumab for proliferative diabetic retinopathy

被引：4
|
作者：
Gibson, Jonathan M. [1 ]
McGinnigle, Samantha [1 ]
机构：
[1] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England
来源：
NATURE REVIEWS ENDOCRINOLOGY | 2016年 / 12卷 / 03期
关键词：
D O I：
10.1038/nrendo.2016.1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The Diabetic Retinopathy Clinical Research Network has published the 2-year results of a 5-year study comparing intravitreous ranibizumab with panretinal laser photocoagulation in patients with proliferative diabetic retinopathy. The results suggest that intravitreous ranibizumab will become a valuable treatment option, although its exact role remains to be defined.
引用
收藏
页码：130 / +
页数：2
相关论文
共 50 条
  • [1] Intravitreous ranibizumab for proliferative diabetic retinopathy
    Jonathan M. Gibson
    Samantha McGinnigle
    Nature Reviews Endocrinology, 2016, 12 : 130 - 131
  • [2] Ghost cell glaucoma after intravitreous injection of ranibizumab in proliferative diabetic retinopathy
    Xu, Jun
    Zhao, Meng
    Li, Ji Peng
    Liu, Ning Pu
    BMC OPHTHALMOLOGY, 2020, 20 (01)
  • [3] Ghost cell glaucoma after intravitreous injection of ranibizumab in proliferative diabetic retinopathy
    Jun Xu
    Meng Zhao
    Ji peng Li
    Ning pu Liu
    BMC Ophthalmology, 20
  • [4] Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy A Randomized Clinical Trial
    Gross, Jeffrey G.
    Glassman, Adam R.
    Jampol, Lee M.
    Inusah, Seidu
    Aiello, Lloyd Paul
    Antoszyk, Andrew N.
    Baker, Carl W.
    Berger, Brian B.
    Bressler, Neil M.
    Browning, David
    Elman, Michael J.
    Ferris, Frederick L., III
    Friedman, Scott M.
    Marcus, Dennis M.
    Melia, Michele
    Stockdale, Cynthia R.
    Sun, Jennifer K.
    Beck, Roy W.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (20): : 2137 - 2146
  • [5] Intravitreous leptin concentrations in patients with proliferative diabetic retinopathy
    Hernández, C
    Lecube, A
    Castellanos, JM
    Segura, RM
    Garat, M
    García-Arumí, J
    Simó, R
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2004, 24 (01): : 30 - 35
  • [6] Intravitreous leptin concentrations in patients with proliferative diabetic retinopathy
    Hernández, C
    Castellanos, JM
    Segura, RM
    García-Arumí, J
    Lecube, A
    Sararols, L
    Cantón, A
    Mesa, J
    Simó, R
    DIABETOLOGIA, 2002, 45 : A345 - A345
  • [7] An exploratory study of vitrectomy with intravitreous ranibizumab instead of panretinal photocoagulation for vitreous hemorrhage from proliferative diabetic retinopathy
    Wei, Yong
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [8] Infographic: Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy (PDR): DRCR.net Protocol S
    Yusuf, Imran H. H.
    Henein, Christin
    Sivaprasad, Sobha
    EYE, 2024, 38 (SUPPL 2) : 37 - 38
  • [9] Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy A Randomized Clinical Trial
    Gross, Jeffrey G.
    Glassman, Adam R.
    Liu, Danni
    Sun, Jennifer K.
    Antoszyk, Andrew N.
    Baker, Carl W.
    Bressler, Neil M.
    Elman, Michael J.
    Ferris, Frederick L.
    Gardner, Thomas W.
    Jampol, Lee M.
    Martin, Daniel F.
    Melia, Michele
    Stockdale, Cynthia R.
    Beck, Roy W.
    JAMA OPHTHALMOLOGY, 2018, 136 (10) : 1138 - 1148
  • [10] Intravitreal ranibizumab for Vitreous hemorrhage in Proliferative Diabetic Retinopathy
    Dirani, Ali
    Fadlallah, Ali
    Azar, George
    Chelala, Elias
    Nehme, Joseph
    Alameddine, Ramzi
    Jalkh, Alexandre
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
12345